Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
Version v14-FR | Version v4-FR | |
---|---|---|
Language | French | French |
Date Updated | 2023-06-15 | 2022-10-11 |
Drug Identification Number | 02469898 | 02469898 |
Brand name | ADMELOG | ADMELOG |
Common or Proper name | Admelog Cartridge | Admelog Cartridge |
Company Name | SANOFI-AVENTIS CANADA INC | SANOFI-AVENTIS CANADA INC |
Ingredients | INSULIN LISPRO | INSULIN LISPRO |
Strength(s) | 100UNIT | 100UNIT |
Dosage form(s) | SOLUTION | SOLUTION |
Route of administration | SUBCUTANEOUS SUBCUTANEOUS | SUBCUTANEOUS SUBCUTANEOUS |
Packaging size | 5 cartridges/box | 5 cartridges/box |
ATC code | A10AB | A10AB |
ATC description | INSULINS AND ANALOGUES | INSULINS AND ANALOGUES |
Reason for shortage | Other (Please describe in comments) | Demand increase for the drug. |
Anticipated start date | ||
Actual start date | 2022-10-07 | 2022-10-07 |
Estimated end date | 2023-07-31 | 2022-10-31 |
Actual end date | 2023-06-14 | |
Shortage status | Resolved | Actual shortage |
Tier 3 Status | No | No |
Company comments | Supply delay. Shortage can be intermittent as Sanofi may receive partial shipments, until full resolution expected on “Estimated end date”. The availability date represents estimated availability at the main Sanofi warehouse. Availability dates at a customer’s usual distributor warehouse may vary. Pharmacies are invited to communicate with their preferred distributor to obtain the product availability date. | Overselling due to SoloStar backorder |
Health Canada comments |